Ikarian Capital
Venture capitalDallas · Pre-Seed–Late Stage
Also known as IKARIAN CAPITAL, LLC
Investment thesis
Ikarian Capital invests in biotech companies advancing drug discovery and development, led by a team with scientific and biotech-specific finance expertise. It selects companies pursuing cutting-edge science with sound business fundamentals across the spectrum of early- to late-stage clinical trials, remaining agnostic to indication, market cap, and geography. The firm deploys transformational, long-term capital to support emerging companies as they progress through the clinic. It emphasizes a selective, contrarian approach backed by a proprietary process aligned with the team's core expertise, and is committed to building an enduring business with strong values and high ethical standards.
Source: firm website, verified Aug 18, 2026.
What they invest in
from 2 of 2 portfolio companiesBiotech ×1Enterprise Software ×1Fintech ×1Healthtech ×1PropTech ×1
HQs:New Zealand×1
Investments · 2 tracked
founders shown can be your intro pathJasper is a commercial real estate fund management firm that deploys and manages capital for institutional investors into industrial, logistics, and other asset classes across Australia and New Zealand.
Enterprise SoftwareFintechPropTechAuckland, NZ
Mark Campbell(CEO and Executive Director)
Co-investorsBlackstoneArc AngelsIcehouse Ventures
Kira Pharmaceuticals develops therapies targeting the complement system for patients with complement-mediated autoimmune and inflammatory diseases across areas including hematology, nephrology, neurology, dermatology and ophthalmology.
BiotechHealthtech
Co-investorsForesite CapitalQuan CapitalVivo Capital
Portfolio news
latest coverage across their companiesJasper · investing.com · Aug 18, 2026

Kira Pharmaceuticals · blockonomi.com · Aug 14, 2026
Frequently asked questions
- What stage does Ikarian Capital invest at?
- Ikarian Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Ikarian Capital focus on?
- Ikarian Capital focuses on Biotech.
- Where is Ikarian Capital located?
- Ikarian Capital is headquartered in Dallas, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Inveready is a Spanish alternative investment firm founded in 2008, offering investment solutions and wealth management services across the small and mid-market segment in Spain.
MSA Capital is a private equity firm based in China that invests in early and growth stage companies in healthcare, technology, internet, and consumer sectors. The firm pursues opportunities with both domestic and international scope.
Medicxi is a life sciences investment firm that focuses on therapeutics across early-stage drug discovery through later development phases.

.png)